SCHEMBL5986922

SCHEMBL5986922

[CH2]CCCC(CC)CCCCC/C=C/CCCCCCCCCC(CC)CCC[CH2]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.34
TRPV1 Q8NER1 2/20 0.34
FFAR1 O14842 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
TRPM8 Q7Z2W7 1/20 0.32
MEN1 O00255 1/20 0.32
CYP3A4 P08684 1/20 0.32
KMT2A Q03164 1/20 0.32
ALDH1A1 P00352 2/20 0.31
LMNA P02545 2/20 0.31
TDP1 Q9NUW8 1/20 0.31
GMNN O75496 1/20 0.31
USP2 O75604 1/20 0.31
CYP1A2 P05177 1/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31
ALOX15 P16050 1/20 0.31
APEX1 P27695 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5986925 1.00 FAAH (0.34) FAAHTRPV1FFAR1FFAR4TRPM8
SCHEMBL5986072 0.96 FAAH (0.34) FAAHTRPV1FFAR1FFAR4TRPM8
SCHEMBL5983868 0.96 FAAH (0.34) FAAHTRPV1FFAR1FFAR4TRPM8
SCHEMBL5984621 0.96 FAAH (0.34) FAAHTRPV1FFAR1FFAR4TRPM8
SCHEMBL5985709 0.96 FAAH (0.34) FAAHTRPV1FFAR1FFAR4TRPM8
SCHEMBL5986251 0.96 FAAH (0.34) FAAHTRPV1FFAR1FFAR4TRPM8
SCHEMBL5985065 0.96 FAAH (0.34) FAAHTRPV1FFAR1FFAR4TRPM8
SCHEMBL5984094 0.96 FAAH (0.34) FAAHTRPV1FFAR1FFAR4TRPM8
SCHEMBL5985456 0.96 FAAH (0.34) FAAHTRPV1FFAR1FFAR4TRPM8
SCHEMBL5986062 0.96 FAAH (0.34) FAAHTRPV1FFAR1FFAR4TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7018993-B2 Antiandrogenic agent CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2006-03-28 US disclosed
US-20030158164-A1 Novel antiandrogenic agent CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-21 US disclosed
EP-1304334-A1 NOVEL ANTIANDROGENIC AGENT CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-04-23 EP disclosed
EP-1219631-A1 ANTIANDROGEN AGENTS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-07-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158164-A1 Novel antiandrogenic agent NR5A1, CYP19A1, HSD17B11 FAAH 1409/4885TRPV1 4436/4885FFAR1 240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.